Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)

NCT01993628 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT01993628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01993628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)
Lead sponsor
University Hospital, Strasbourg, France
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2013
Completion date
November 30, 2016
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, lewy body's dementia